Approved Hospital Formulary
Add Formweb to your mobile device
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Search results for:
inotuzumab ozogamicin
inotuzumab ozogamicin
- Restricted Besponsa --> Restricted to hospital outpatient setting (infusion centers, clinics) by oncology.
- Restricted Anti-Neoplastic Formulary
Last updated: Mar. 5, 2025
- Black Box Warning: Hepatotoxicity, Including VOD; Increased Risk of Post-HSCT Non-Relapse Mortality
- HAZ-MED: Table 1
- Formulary, Not Routinely Stocked:
Besponsa is restricted to outpatient oncology/infusion centers. Not routinely stocked.
Reviewed: 23 Jan 2018